REGENXBIO
RGNX
$16.19
Share price
0.81%
Change (1 day)
-13.19%
Change (1 year)
Categories
REGENXBIO (RGNX) - Total debt
Total debt on the balance sheet as of December 2023 : $89.29 M
According to REGENXBIO's latest financial reports the company's total debt is $89.29 M. A company’s total debt is the sum of all current and non-current debts.
REGENXBIO - Total debt on balance sheet (from 2014 to 2023)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2023-12-31 | $89.29 M | -5.81% |
| 2022-12-31 | $94.79 M | 9.37% |
| 2021-12-31 | $86.68 M | 19.31% |
| 2020-12-31 | $72.65 M | 543.23% |
| 2019-12-31 | $11.29 M | 92.94% |
| 2018-12-31 | $5.85 M | |
| 2017-12-31 | $N/A | |
| 2014-12-31 | $2.4 M | |
| 2013-12-31 | $N/A |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $2.75 M | -96.92% | 🇺🇸 USA |